Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has submitted a general update disclosure to NSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. Regulation 30 filings are used by listed companies to inform the exchange about material events or developments that may impact the company or its shareholders. The specific nature of the update is not stated in the headline and would need to be reviewed in the full filing. Without further details, the exact subject matter — whether operational, regulatory, or financial — cannot be determined.
Since the announcement headline only references a generic Regulation 30 update with no specific details on numbers, business developments, or financial impact, investors should look at the full filing on NSE/BSE to understand any material implications for the company or stock price.